Low-dose acetylsalicylic acid inhibits the secretion of interleukin-6 from white adipose tissue (Q42444302)

31 October 2017

Low-dose acetylsalicylic acid inhibits the secretion of interleukin-6 from white adipose tissue (English)

1 reference

31 October 2017

R Bhome

4

0 references

Derek W Gilroy

object named as

D Gilroy

7

0 references

author name string

N C Ogston

1

1 reference

31 October 2017

K Karastergiou

2

1 reference

31 October 2017

M J Hosseinzadeh-Attar

3

1 reference

31 October 2017

R Madani

5

1 reference

31 October 2017

M Stables

6

1 reference

31 October 2017

P Flachs

8

1 reference

31 October 2017

M Hensler

9

1 reference

31 October 2017

J Kopecky

10

1 reference

31 October 2017

V Mohamed-Ali

11

1 reference

31 October 2017

language of work or name

English

0 references

publication date

4 November 2008

1 reference

International Journal of Obesity

31 October 2017

1 reference

31 October 2017

32

1 reference

31 October 2017

12

1 reference

31 October 2017

1807-1815

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2008.190

31 October 2017

0 references

cites work

Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Interleukin-1beta induces interleukin-6 production through the production of prostaglandin E(2) in human osteoblasts, MG-63 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

The regulation of interleukin-6 secretion by prostanoids and members of the tumor necrosis factor superfamily in fresh villous fragments of term human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Release and effects of prostaglandins in adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Cell surface receptors, nuclear receptors and ligands that regulate adipose tissue development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Prostaglandin D2 synthase enzymes and PPARgamma are co-expressed in mouse 3T3-L1 adipocytes and human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Factors regulating the production of prostaglandin E2 and prostacyclin (prostaglandin I2) in rat and human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Cyclooxygenase-mediated prostaglandin F2alpha is decreased in an elderly population treated with low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Comparison of PGE2, prostacyclin and leptin release by human adipocytes versus explants of adipose tissue in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Arachidonic acid stimulates interleukin-6 release from rat peritoneal macrophages in vitro: evidence for a prostacyclin-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

7 January 2021

Effects of interleukin 6 on megakaryocytes and on canine platelet function

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

7 January 2021

Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

7 January 2021

Prostanoid receptors: structures, properties, and functions

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

7 January 2021

Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

7 January 2021

COX-2 inhibitors selectively block prostacyclin synthesis in endotoxin-exposed vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

7 January 2021

Thromboxane A2 promotes interleukin-6 biosynthesis mediated by an activation of cyclic AMP-response element-binding protein in 1321N1 human astrocytoma cells

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

7 January 2021

Differential expression of prostaglandin receptor mRNAs during adipose cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2008.190

7 January 2021

Identifiers

DOI

10.1038/IJO.2008.190

1 reference

31 October 2017

1 reference